Floatz logo

BENZOIC ACID, 4-AMINO-2-CHLORO-, 2-(DIETHYLAMINO)ETHYL ESTER

Pain

AstesSmall moleculePhase 4 / ApprovedDormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
81/ 100

Competitive context

44 Active assets in the Pain cohort.

Asset / SponsorPhaseRating
NEPENTHE
Bursa City Hospital
Phase 4BBB
FENTANYL
Aga Khan University
Phase 4BBB
Tapentadol
Grünenthal GmbH
Phase 4BBB
Oxycodone
The First Affiliated Hospital with Nanjing Medical University
Phase 4BBB
Nabiximols
Jazz Pharmaceuticals
Phase 3BBB

View all 50 →

Same molecule, other indications

BENZOIC ACID, 4-AMINO-2-CHLORO-, 2-(DIETHYLAMINO)ETHYL ESTER is also rated in:

Neuropathic PainDormant
D
Indicative ·
30 / 100
View asset →
Phantom Limb PainDormant
D
Indicative ·
30 / 100
View asset →
AmputationDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →